文献速递中医内科中药与中成药合理使用

中药天然化合物调控缺血性卒中微胶质细胞反应的机制

Regulatory mechanisms of natural compounds from traditional Chinese herbal medicines on the microglial response in ischemic stroke.
PubMed 文献 · Phytomedicine · 2023-05-20

综述总结中药天然化合物在缺血性卒中动物模型中对微胶质细胞反应的调控机制,检索截至2023年4月10日的Web of Science、PubMed和ScienceDirect数据库,遵循PRISMA指南。天然化合物通过抑制NF-κB、MAPKs、JAK/STAT等通路减弱促炎M1表型,通过激活Nrf2/HO-1、PI3K/AKT等通路增强神经保护性M2表型。部分临床试验显示调控微胶质细胞反应的中药天然化合物具有显著且安全的治疗作用,但仍需进一步精心设计的临床研究。

要点

  • 中药天然化合物可抑制微胶质细胞M1促炎表型,涉及NF-κB、MAPKs、JAK/STAT等通路。
  • 中药天然化合物可激活Nrf2/HO-1、PI3K/AKT等通路增强微胶质细胞M2神经保护反应。
  • 部分临床试验显示调控微胶质细胞反应的中药天然化合物具有显著且安全的治疗作用。

核心结论

  • 中药天然化合物通过多通路调控微胶质细胞M1/M2极化,在缺血性卒中动物模型中发挥神经保护作用。
  • 部分临床试验显示调控微胶质细胞反应的中药天然化合物具有显著且安全的治疗作用,但需进一步验证。

研究设计与样本

  • 综述检索Web of Science、PubMed和ScienceDirect数据库截至2023年4月10日的文献,遵循PRISMA指南。
  • 检索关键词包括natural compounds、natural products或phytochemicals、traditional Chinese Medicine或Chinese herbal medicine、microglia、ischemic stroke。

主要发现

  • 中药天然化合物通过抑制NF-κB、MAPKs、JAK/STAT、Notch、TLR4、P2X7R、CX3CR1、IL-17RA、NLRP3炎症小体和促氧化酶减弱微胶质细胞M1促炎表型。
  • 中药天然化合物通过激活Nrf2/HO-1、PI3K/AKT、AMPK、PPARγ、SIRT1、CB2R、TREM2、nAChR和IL-33/ST2增强微胶质细胞M2神经保护反应。
  • 部分临床试验显示调控微胶质细胞反应的中药天然化合物具有显著且安全的治疗作用。

临床怎么用

  • 可关注中药天然化合物通过调控微胶质细胞M1/M2极化治疗缺血性卒中的潜在价值。
  • 临床转化需进一步开展精心设计的临床试验验证疗效与安全性。

局限性

  • 天然化合物的直接靶点及潜在多效性或协同效应尚需进一步研究。
  • 现有临床试验证据有限,需更多精心设计的临床研究确认。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Development of clinically effective neuroprotective agents for stroke therapy is still a challenging task. Microglia play a critical role in brain injury and recovery after ischemic stroke. Traditional Chinese herbal medicines (TCHMs) are based on a unique therapeutic principle, have various formulas, and have long been widely used to treat stroke. Therefore, the active compounds in TCHMs and their underlying mechanisms of action are attracting increasing attention in the field of stroke drug development. PURPOSE: To summarize the regulatory mechanisms of TCHM-derived natural compounds on the microglial response in animal models of ischemic stroke. METHODS: We searched studies published until 10 April 2023 in the Web of Science, PubMed, and ScienceDirect using the following keywords: natural compounds, natural products or phytochemicals, traditional Chinese Medicine or Chinese herbal medicine, microglia, and ischemic stroke. This review was prepared according to PRISMA (Preferred Reporting Item for Systematic Reviews and Meta-Analysis) guidelines. RESULTS: Natural compounds derived from TCHMs can attenuate the M1 phenotype of microglia, which is involved in the detrimental inflammatory response, via inhibition of NF-κB, MAPKs, JAK/STAT, Notch, TLR4, P2X7R, CX3CR1, IL-17RA, the NLRP3 inflammasome, and pro-oxidant enzymes. Additionally, the neuroprotective response of microglia with the M2 phenotype can be enhanced by activating Nrf2/HO-1, PI3K/AKT, AMPK, PPARγ, SIRT1, CB2R, TREM2, nAChR, and IL-33/ST2. Several clinical trials showed that TCHM-derived natural compounds that regulate microglial responses have significant and safe therapeutic effects, but further well-designed clinical studies are needed. CONCLUSIONS: Further research regarding the direct targets and potential pleiotropic or synergistic effects of natural compounds would provide a more reasonable approach for regulation of the microglial response with the possibility of successful stroke drug development.

来源:Phytomedicine,查看原文。版权归原作者所有。

引用

  1. Ri MH, Xing Y, Zuo HX, et al. Regulatory mechanisms of natural compounds from traditional Chinese herbal medicines on the microglial response in ischemic stroke. Phytomedicine. 2023. PMID: 37262999. doi:10.1016/j.phymed.2023.154889

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。